

Results-driven R&D Scientist and team leader with over 18+ years of experience in biopharmaceuticals specializing in biosimilars and vaccines. Possesses deep expertise in genetic engineering, clone development, and recombinant protein expression in microbial and mammalian systems for biotherapeutic applications. Adept at leading multidisciplinary teams, mentoring scientists, and driving cross-functional collaborations with process development teams to deliver impactful research outcomes.
Genetic Engineering/Clone development
Gene synthesis strategy design, Vector host selection, and gene integration using multiple cloning methods; Restriction cloning, Gibson assembly, Topo cloning and site directed mutagenesis
Insilico vector designing and optimizing strategies for high yield recombinant proteins in multiple microbial and yeast host systems such as E coli, Saccharomyces cerevisiae, Pichia pastoris
Hands-on molecular biology and bioanalytical techniques, including end-point PCR, RT-PCR/qPCR, agarose gel electrophoresis (horizontal and vertical), SDS-PAGE, Western blotting
Strong working knowledge of advanced DNA assembly techniques, including Gibson assembly across bacterial, yeast, and fungal hosts
Ecoli expression of small proteins (Teriparatide, Genotropin, Human IL6), mammalian expression (heavy and Light antibody chains, ScFvs, Dengue viral antigens, Rabies Glycoproteins and Erythropoietin (EPO) in CHO cell lines
Cell Culture & Bioprocessing
Transient transfection (Chemical/electroporation) and Stable Cell line development CHO DHFR (-) - CHO GS (-) and clone screening for EPO therapeutic protein for high expression
Design and execute experiments using mammalian cell culture and transfection techniques
Revival, maintenance, cryopreservation of mammalian suspension/adherent cells, (CHO, HEK 293, HpeG2, Vero, BHK 21, ExpiCHO-S, Carcinogenic hybridomas)